Education and support program for people with advanced kidney disease and high blood pressure
Tests education and support for hospitalized adults with advanced kidney disease.
Key facts
- Who runs it
- University of Chicago
- Where
- Chicago, United StatesSee the site
- Trial code
- Registry title
- Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
- Status
- Recruiting
- People taking part
- 180 people, planned
- Started
- 4 Sept 2024
- Planned end
- 30 Jun 2026
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- In-Person Patient Education
- Commitment to Change
- Blood pressure monitoring
- Written Patient Education
- Text-based reinforcement for CKD self-management
- Community-based education session, reinforcement for self-management
- Text-based reinforcement for general health self-management
- Record updated
- 14 November 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for Black or African American adults with advanced chronic kidney disease who are in the hospital at the University of Chicago and expected to stay more than 48 hours.
- Age
- Over 18 and under 70 years.
- Sex
- All sexes can join.
- Disease stage
- Advanced chronic kidney disease: Stage 3B or above, or eGFR<45 during the hospital stay and in earlier medical visits.
- Biomarker or test result
- eGFR<45 during admission and in previous medical encounters.
Main reasons for not taking part
- Does not speak English
- Cannot communicate because of current medical condition
- Cannot give consent because of mental status
- Expected hospital stay less than 24 hours
- Currently in the ICU
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Patients over the age of 18 and under 70
- Admitted to the University of Chicago inpatient general medicine service
- Likely hospital stay greater than 48 hours
- Diagnosis of advanced CKD (Stage 3B or above, as determine by problem list, ICD- 10 codes or eGFR<45 during admission and from previous medical encounters)
- Self-identify as Black or African American
Who cannot take part
- Non-English speaking
- Unable to communicate due to current medical status
- Unable to consent due to mental status
- Expected hospital stay less than 24 hour
- Current admission in ICU
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
Where in United States
- University of Chicago Medical CenterChicago, United StatesContact: Milda Saunders, MDTaking people
About the trial
What the trial wants to find out
Intensive Patient Referral and Education Program prior to Renal Replacement Therapy (iPREP-RRT) is a 12-week intervention that identifies hospitalized African Americans with advanced chronic kidney disease (CKD) and provides them with hospital- and community-based education, navigation and self-management support. Participants will be randomized to the iPREP-RRT intervention versus enhanced usual care.
The 2 groups in the trial
- Intensive Intervention (iPREP RRT)Treatment being tested
The intervention is administered by a patient educator (PE), a culturally concordant health educator. S/he will review the CKD and RRT education materials on a tablet device with the participant, answer any questions they have, and using motivational interviewing techniques get a commitment for future action. The participant and the patient educator will work together to decide on potential CKD self-management and RRT options and/or next steps. The PE will teach the participant how to use the home blood pressure monitor and will leave it with the participant. The patient educator will check in with the participant through text messages and follow-up phone calls.
Treatment: In-Person Patient Education, Commitment to Change, Blood pressure monitoring, Text-based reinforcement for CKD self-management, and Community-based education session, reinforcement for self-management
- Enhanced Usual CarePlacebo, for comparison
The enhanced usual care is administered by a patient educator (PE), a culturally concordant health educator. The PE will drop off written general health education materials. The patient educator will check in with the participant through text messages.
Treatment: Written Patient Education and Text-based reinforcement for general health self-management
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
- Plain-language title
- Education and support program for people with advanced kidney disease and high blood pressureGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06397456, who can take part
- Record updated
- 14 November 2025